Latest filing published 01 Oct 2020 for Maxcyte, INC., €97k.
Filing timeline
BuySaleInsider track record
J. Stark Thompson: trading record in brief
J. Stark Thompson discloses dealings in Maxcyte, Inc. to SEC (Form 4). Between 28 February 2018 and 1 October 2020, the trades on record add up to 2 filings.
Sales make up the whole of the open-market record (2 sales, €164k). So far in 2020, the count stands at no purchases and 1 sale.
The latest filing, published on 1 October 2020, reports an open-market sale of €97k in Maxcyte, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to J. Stark Thompson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ £3.5559.2% of flowLondon Stock Exchange, AIM Market (XLON)ISIN US57777K1060FCA-NSM:3734253
- 24,000 shares@ £2.46100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN US57777K1060FCA-NSM:LSE20180228170028_13549898_20200330111411984_86
2 of 2 declarations
